Board logo

subject: Conjuchem Biotechnologies Inc. (cjb) - Financial And Strategic Analysis Review - Aarkstore Enterpris [print this page]


Aarkstore announce a new report "ConjuChem Biotechnologies Inc. (CJB) - Financial and Strategic Analysis Review " through its vast collection of market research report.

ConjuChem Biotechnologies Inc. (ConjuChem) is a publicly held Canada-based biotechnology company. The company is principally engaged in the discovery of novel therapeutics with an initial focus on diabetes. The company makes use of its platforms namely drug affinity complex (DAC) and preformed conjugate drug affinity complex (PC-DAC) to develop new drugs. The technologies enable the creation of new drugs with enhanced therapeutic properties when applied to peptides, as compared to the original peptide. ConjuChem also provides drugs to treat an array of pathologies, such as diabetes, cancer and human immunodeficiency virus (HIV).

ConjuChem Biotechnologies Inc. Key Recent Developments

Feb 26, 2010: ConjuChem Files For Restructuring

Jan 19, 2010: ConjuChem Establishes Committee To Evaluate Strategic Alternatives

Dec 21, 2009: USPTO Issues Final Office Action In Amylin Patent Reexamination

This comprehensive SWOT profile of ConjuChem Biotechnologies Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ConjuChem Biotechnologies Inc., including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days (excluding weekends).

The profile contains critical company information including*,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

For more information, please visit:

http://www.aarkstore.com/reports/ConjuChem-Biotechnologies-Inc-CJB-Financial-and-Strategic-Analysis-Review-50272.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise




welcome to Insurances.net (https://www.insurances.net) Powered by Discuz! 5.5.0   (php7, mysql8 recode on 2018)